https://www.selleckchem.com/pr....oducts/2-hydroxybenz
inson and Movement Disorder Society. Our data indicate that 18 F-GE-180 PET detects microglial activation in the brain of patients with 4-repeat tauopathy, fitting to predilection sites of the phenotype. The 18 kDa translocator protein PET has a potential for monitoring neuroinflammation in 4-repeat tauopathies. © 2020 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.Since the publication of the Japanese "Guidelines for the management of cu
Like
Comment
Share
